<DOC>
	<DOCNO>NCT02865824</DOCNO>
	<brief_summary>Current guideline recommend discontinuation antiplatelets ( i.e clopidogrel ) 7 day patient take DAT ( dual antiplatelet therapy ) colonoscopy polypectomy . The purpose study examine ) discontinuation drug reduce bleed risk polypectomy b ) discontinuation drug increase occurence thromboembolic event .</brief_summary>
	<brief_title>Polypectomy Patients Taking Dual Antiplatelet Agents</brief_title>
	<detailed_description>Patients take dual antiplatelets ( DAT ) visit colonoscopy eligible enrollment study . On enrollment , patient randomize two group . One group continue DAT group discontinue antiplatelets ( i.e . clopidogrel , ticagrelor , prasugrel ) 7 day colonoscopy . If polyp ( â‰¤1 cm ) observe colonoscopy , remove cold snare polypectomy . The primary aim compare delayed bleed rate two group .</detailed_description>
	<mesh_term>Colonic Polyps</mesh_term>
	<criteria>patient age 20 year undergoing routine colonoscopy patient take DAT ( dual antiplatelet therapy ) patient abide study protocol history inflammatory bowel disease severe comorbidities American Society Anesthesiology class III pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Colonoscopy</keyword>
</DOC>